Biozhem Cosmeceuticals Inc. Announces 45-Day Test Results.Business Editors and Health/Medical Writers SAN JUAN CAPISTRANO San Juan Capistrano (săn wän kăpĭsträ`nō), city (1990 pop. 26,183), Orange co., S Calif.; inc. 1961. San Juan Capistrano has some manufactures, including aircraft parts, medical apparatus, and boats, but the economy is , Calif.--(BUSINESS WIRE)--May 16, 2001 Biozhem Cosmeceuticals Inc., (Biozhem), (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BZHM) today announced the mid-point results of its clinical efficacy study for treating the signs and symptoms of aging facial skin with a new bioengineered skin care treatment. Dermtech International of San Diego, an independent testing facility, is conducting the study on Biozhem's behalf. A panel of 36 women between the ages of 35-55 showed significant changes in the appearance of aged skin. The five most prominent parameters were skin roughness, number of fine line wrinkles, depth of wrinkles, space between wrinkles, and "shadowing" skin luminance The amount of brightness, measured in lumens, that is given off by a pixel or area on a screen. For example, dark red and bright red would have the same chrominance, but a different luminance. . Subjects were instructed to apply the cream to the peri-ocular fine (crow's feet) lines around the eyes twice daily for 45 days. Clinical photography and image analysis from silicon replicas taken around the eyes revealed a 45% decrease in the depth of fine line wrinkle appearance as compared WITH the control. Overall skin roughness appeared to improve by 72% vs. the control. The bioengineered product reduced the overall appearance of total fine line wrinkles by 58% vs. the control. John Riemann, chairman of the board of Biozhem, stated: "We are very excited that our new product appears to produce such dramatic results in such a short period of time. We are actively preparing for the launch of our new bioengineered product line, which will be commercially available this summer." The Biozhem anti-aging skin care line, Cell Life Protein B Complex, has as its active ingredient NouriCel(TM). NouriCel(TM) is produced by Advanced Tissue Sciences of La Jolla, Calif. (Nasdaq:ATIS ATIS - A Tools Integration Standard ) as an enriched nutrient solution byproduct by·prod·uct or by-prod·uct n. 1. Something produced in the making of something else. 2. A secondary result; a side effect. Noun 1. of their patented tissue engineering processes. NouriCel(TM) contains a unique cocktail of naturally derived human growth factors, soluble collagens matrix proteins, amino acids and powerful antioxidants Antioxidants Substances that reduce the damage of the highly reactive free radicals that are the byproducts of the cells. Mentioned in: Aging, Nutritional Supplements antioxidants, n. . Biozhem has the exclusive international rights to the direct market for NouriCel(TM). Cell Life Protein B Complex adds to the skin's natural repair processes, making the skin look and feel younger and more vibrant. Biozhem Cosmeceuticals is a specialty retailer of premium quality skin care products for men and women. For further information, contact Biozhem investor relations Investor relations The process by which the corporation communicates with its investors. at 888/215-9630. Statements about the company's future expectations and all other statements in this news release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that is defined in the Private Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. Reform Act of 1995. The company intends that such forward-looking statements be subject to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results could differ materially from expected results. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion